# A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke

Study · id `cardio:ct-nct02072226` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02072226](<https://clinicaltrials.gov/study/NCT02072226>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02072226

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 313 participants.

## Technical summary

Registry record NCT02072226. Randomized; double masking; primary purpose treatment. Start 2014-05-31 (actual); primary completion 2017-03-22 (actual). Results posted on 2018-07-03.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 313 participants (enrolled count; ClinicalTrials.gov record NCT02072226, source copy `cardio:ctgov-nct02072226-2018-07-03`, retrieved 2026-10-26)
- Started: 2014-05-31 (actual) (ClinicalTrials.gov record NCT02072226, source copy `cardio:ctgov-nct02072226-2018-07-03`, retrieved 2026-10-26)
- Primary completion: 2017-03-22 (actual) (ClinicalTrials.gov record NCT02072226, source copy `cardio:ctgov-nct02072226-2018-07-03`, retrieved 2026-10-26)
- Completion: 2017-03-22 (actual) (ClinicalTrials.gov record NCT02072226, source copy `cardio:ctgov-nct02072226-2018-07-03`, retrieved 2026-10-26)
- Results first posted: 2018-07-03 (ClinicalTrials.gov record NCT02072226, source copy `cardio:ctgov-nct02072226-2018-07-03`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02072226, source copy `cardio:ctgov-nct02072226-2018-07-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02072226-2018-07-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke
- Acronym: PRISMS
- Condition: Stroke
- Intervention (Drug): Alteplase
- Intervention (Drug): Alteplase Placebo
- Intervention (Drug): Aspirin
- Intervention (Drug): Aspirin Placebo
- Lead sponsor: Genentech, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: Genentech, Inc. (`cardio:org-genentech-inc`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial (`cardio:pubmed-29998337`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 89c0c06764a41d2a4ed08f29450f79ff678349244cf589da9118a73aac40e855
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
